A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma (Q67903051)
scientific article published on 01 September 1991
Language:
Current Data About A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma
(P31) (Q13442814)
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833042%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P50) (Q94375040)
(P1545) 3
(P1932) D. Niedzwiecki
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833042
(P813) Monday, December 5, 2022

(P304) 965-969
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833042%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P407) (Q1860)

(P433) 5
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833042%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P478) 68
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833042%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P577) Sunday, September 1, 1991
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833042%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P921) (Q42824827)
(P887)

(Q178425)

(Q18556536)
(P887)

(Q180983)
(P887)

(Q412415)
(P887)

(Q238512)
(P887)

(Q162555)
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(P953) https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(P1433) (Q326041)
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833042%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P1476) "A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma" (language: en)
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1833042%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 19, 2019

(P2093) D. Kelsen
(P1545) 1
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833042
(P813) Monday, December 5, 2022

C. Hudis
(P1545) 2
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833042
(P813) Monday, December 5, 2022

J. Dougherty
(P1545) 4
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833042
(P813) Monday, December 5, 2022

E. Casper
(P1545) 5
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833042
(P813) Monday, December 5, 2022

J. Botet
(P1545) 6
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833042
(P813) Monday, December 5, 2022

V. Vinciguerra
(P1545) 7
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833042
(P813) Monday, December 5, 2022

R. Rosenbluth
(P1545) 8
(P248)
(P698) 1833042
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833042
(P813) Monday, December 5, 2022

(P2860) (Q70937645)
(P1545) 2
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q70017534)
(P1545) 3
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q34683749)
(P1545) 4
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q69551029)
(P1545) 8
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q36045249)
(P1545) 9
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q27710285)
(P1545) 10
(P478) 64
(P304) 151
(P2093) Cohen
(P577) Tuesday, January 1, 1980
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q29620070)
(P1545) 12
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q50622722)
(P1545) 13
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q25938997)
(P1545) 16
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q60895214)
(P1545) 17
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q27710285)
(P1545) 18
(P478) 70
(P304) 929
(P2093) Desimone
(P577) Wednesday, January 1, 1986
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q27710285)
(P1545) 19
(P478) 68
(P304) 1053
(P2093) Sternberg
(P577) Sunday, January 1, 1984
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q71245225)
(P1545) 20
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q70062030)
(P1545) 21
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q70409184)
(P1545) 22
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

(Q27710285)
(P1545) 23
(P478) 71
(P304) 1115
(P2093) Loehrer
(P577) Thursday, January 1, 1987
(P248)
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P854) https://api.crossref.org/works/10.1002/1097-0142(19910901)68:5%3C965::AID-CNCR2820680509%3E3.0.CO;2-2
(P813) Monday, December 5, 2022

other details
description scientific article published on 01 September 1991

External Links
(P356) 10.1002/1097-0142(19910901)68:5<965::AID-CNCR2820680509>3.0.CO;2-2
(P698) 1833042